(120 days)
Not Found
No
The document describes a standard clinical chemistry analyzer using photometric and ion-selective electrode technology, with no mention of AI or ML.
No
The device is an in vitro diagnostic chemistry analyzer used for quantitative measurements of various substances in biological samples, primarily for diagnosis and monitoring, not for direct therapy.
Yes
Explanation: The device is designed for making direct quantitative measurements of various substances (Na+, K+, Cl-, Urea Nitrogen) in biological samples (serum, plasma, urine) and is used in clinical chemistry laboratories for the diagnosis and treatment of diseases. This aligns with the definition of a diagnostic device.
No
The device is described as an automated clinical chemistry analyzer, which is a hardware device. It performs photometric assays and has an optional Ion-Selective Electrode (ISE) module, both of which are hardware components.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states that the device is "designed for clinical chemistry laboratory use, making direct quantitative measurements of Na+(sodium), K+(potassium), Cl- (chloride) in serum, plasma and urine samples, and Urea Nitrogen in serum samples." It also mentions that the ISE Kit is "for the in vitro quantitative determination of Sodium (Na+), Potassium (K+), and Chloride (Cl-) concentrations in serum, plasma and urine samples." These are all activities performed in vitro (outside the body) on biological samples to provide information for diagnosis or treatment.
- Device Description: The description confirms it's an "automated clinical chemistry analyzer capable of performing various in vitro photometric assays."
- Purpose of Measurements: The document details how the measurements of Na+, K+, Cl-, and Urea Nitrogen are used "in the diagnosis and treatment of diseases involving electrolyte imbalance," "disease conditions characterized by, low or high blood potassium levels," "electrolyte and metabolic disorders," and "to aid in the determination of liver and kidney function and other diseases associated with protein catabolism." This directly aligns with the definition of an IVD, which is used to examine specimens from the human body to provide information for clinical purposes.
- Predicate Device: The predicate device listed (K072018 BS-200 Chemistry Analyzer) is also a clinical chemistry analyzer, which are typically classified as IVDs.
Therefore, based on the provided information, the BS-800M/ABS800/BA-800M Chemistry Analyzer and its associated ISE Kit are clearly intended for in vitro diagnostic use.
N/A
Intended Use / Indications for Use
The BS-800M/ABS800/BA-800M Chemistry Analyzer is designed for clinical chemistry laboratory use, making direct quantitative measurements of Na+(sodium), K+(potassium), Cl- (chloride) in serum, plasma and urine samples, and Urea Nitrogen in serum samples. Additionally, other various chemistry tests may be adaptable to the analyzer depending on the reagent used to induce a photometric reaction.
The BS-800M/ABS800/BA-800M ISE Kit is for the in vitro quantitative determination of Sodium (Na+), Potassium (K+), and Chloride (Cl-) concentrations in serum, plasma and urine samples on the The BS-800M/ABS800/BA-800M Chemistry Analyzer.
Sodium measurements monitor electrolyte balance and in the diagnosis and treatment of diseases involving electrolyte imbalance.
Potassium measurements monitor electrolyte balance and in the diagnosis and treatment of disease conditions characterized by, low or high blood potassium levels.
Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders.
Urea Nitrogen (BUN) measurements are used to aid in the determination of liver and kidney function and other diseases associated with protein catabolism.
Product codes (comma separated list FDA assigned to the subject device)
JGS, CGZ, CGZ, CEM, CDQ, JJE
Device Description
The BS-800M/BA-800M/ABS800 Chemistry Analyzer is an automated clinical chemistry analyzer capable of performing various in vitro photometric assays. The BUN (LIQUID) REAGENT SET was cleared under K972671 and is the chosen assay to demonstrate performance for the photometric unit. The BS-800M Chemistry Analyzer has an optional Ion-Selective Electrode (ISE) module which measures the concentration of the electrolytes, sodium, potassium, and chloride, in samples using ion selective electrode technology.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Clinical chemistry laboratory use
Clinical Lab
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing of the BS-800M Chemistry Analyzer consisted of running the FDA previously cleared assay and the ISE module on the BS-800M to evaluate precision, linearity, and method comparison, Limits of Detection and Limits of Quantitation, interference, ISE plasma sample type studies.
A correlation analysis between the BS-800M Chemistry Analyzer and BS-200 Chemistry Analyzer yielded the following results (Sample Range, N, Slope, Intercept, Correlation Coefficient):
BUN: 5.4-149.5 mg/dL, 122, 0.98, 0.81, 0.9997
Serum Na+: 100.2-196.4 mmol/L, 124, 1.03, -5.95, 0.9966
Serum K+: 1.40-7.70 mmol/L, 121, 1.04, -0.09, 0.9994
Serum Cl-: 50.4-149.4 mmol/L, 124, 1.00, 0.15, 0.9993
Urine Na+: 12.1-395.4 mmol/L, 120, 0.99, -2.52, 0.9997
Urine K+: 5.1-194.7 mmol/L, 120, 0.98, -1.00, 0.9997
Urine Cl-: 15.2-381.3 mmol/L, 120, 0.97, 2.06, 0.9988
The bias at the medical decision points of method comparison yielded the following results (Point 1, Point 2, Point 3 for Medical decision points and Bias):
BUN: 6 mg/dL (0.696/11.6%), 26 mg/dL (0.317/1.2%), 50 mg/dL (-0.138/-0.3%)
Serum Na+: 115 mmol/L (-2.713/-2.4%), 135 mmol/L (-2.149/-1.6%), 150 mmol/L (-1.727/-1.2%)
Serum K+: 3.0 mmol/L (0.032/1.1%), 5.8 mmol/L (0.144/2.5%), 7.5 mmol/L (0.212/2.8%)
Serum Cl-: 90 mmol/L (0.245/0.3%), 112 mmol/L (0.267/0.2%)
Urine Na+: 40 mmol/L (-2.759/-6.9%), 112 mmol/L (-3.837/-1.7%)
Urine K+: 25 mmol/L (-1.418/-5.7%), 125 mmol/L (-3.085/-2.5%)
Urine Cl-: 110 mmol/L (-1.112/-1.0%), 250 mmol/L (-5.147/-2.1%)
Total precision test of BS-800M (n=80):
BUN: Control pool 1 Mean 11.0, Repeatability SD 0.28, CV% 2.5%, Within-Device Precision SD 0.33, CV% 3.0%; Control pool 2 Mean 46.4, Repeatability SD 0.57, CV% 1.2%, Within-Device Precision SD 0.94, CV% 2.0%
Serum Na+: Control pool 1 Mean 136.1, Repeatability SD 0.35, CV% 0.3%, Within-Device Precision SD 0.83, CV% 0.6%; Control pool 2 Mean 166.1, Repeatability SD 0.46, CV% 0.3%, Within-Device Precision SD 1.12, CV% 0.7%
Serum K+: Control pool 1 Mean 3.72, Repeatability SD 0.006, CV% 0.2%, Within-Device Precision SD 0.021, CV% 0.6%; Control pool 2 Mean 6.10, Repeatability SD 0.013, CV% 0.2%, Within-Device Precision SD 0.033, CV% 0.5%
Serum CL-: Control pool 1 Mean 89.4, Repeatability SD 0.21, CV% 0.2%, Within-Device Precision SD 0.38, CV% 0.4%; Control pool 2 Mean 107.5, Repeatability SD 0.23, CV% 0.2%, Within-Device Precision SD 0.44, CV% 0.4%
Urine Na+: Control pool 1 Mean 87.1, Repeatability SD 0.22, CV% 0.3%, Within-Device Precision SD 0.44, CV% 0.5%; Control pool 2 Mean 148.6, Repeatability SD 0.36, CV% 0.2%, Within-Device Precision SD 0.74, CV% 0.5%
Urine K+: Control pool 1 Mean 35.1, Repeatability SD 0.08, CV% 0.2%, Within-Device Precision SD 0.21, CV% 0.6%; Control pool 2 Mean 68.8, Repeatability SD 0.16, CV% 0.2%, Within-Device Precision SD 0.41, CV% 0.6%
Urine Cl-: Control pool 1 Mean 90.4, Repeatability SD 0.20, CV% 0.2%, Within-Device Precision SD 0.40, CV% 0.4%; Control pool 2 Mean 133.9, Repeatability SD 0.17, CV% 0.1%, Within-Device Precision SD 0.48, CV% 0.4%
Linearity test of BS-800M (Slope, Intercept, Correlation Coefficient, Linear Range Tested, Claimed Linear Range):
BUN: 0.9999, 0.0053, 0.9996, 4.5-162.6, 5-150
Serum Na+: 0.9996, 0.0783, 1.0000, 41.9-224.4, 100-200
Serum K+: 0.9997, -0.0003, 0.9999, 0.61-9.34, 1-8
Serum Cl-: 0.9998, 0.0389, 0.9999, 11.0-162.4, 50-150
Urine Na+: 1.0000, 0.0139, 0.9999, 7.5-469.5, 10-400
Urine K+: 1.0001, 0.0175, 0.9999, 3.1-254.4, 5-200
Urine Cl-: 1.0000, 0.0370, 0.9999, 10.9-439.4, 15-400
Detection limit studies test of BS-800M (LoB, LoD, LoQ):
BUN: 0.4, 0.9, 4.2
Serum Na+: 1.9, 3.5, 39.5
Serum K+: 0.04, 0.05, 0.54
Serum Cl-: 0.5, 0.6, 9.5
Urine Na+: 0.9, 1.4, 6.9
Urine K+: 0.1, 0.2, 2.4
Urine Cl-: 0.2, 0.3, 9.8
Interference test of BS-800M:
No significant interference (NSI) was observed when concentrations of bilirubin, lipemia, and ascorbic acid were within tested levels (Bilirubin 40 mg/dL, Lipemia 1000 mg/dL, Ascorbic Acid 30 mg/dL).
Significant interference was observed for hemoglobin and Potassium Thiocynate for specific analytes.
- Avoid hemolyzed samples for potassium, as they may give incorrect elevated results.
- Potassium thiocynate increases potassium by 0.55 mmol/L at 3.30 mmol/L and by 0.58 mmol/L at 5.39 mmol/L.
- Potassium thiocynate increases chloride by 12.3 mmol/L at 90.9 mmol/L and by 12.6 mmol/L at 114.6 mmol/L.
Sample type studies between serum and plasma for Na, K, Cl tests (N=51):
Na+: Slope 1.000, Intercept -0.33, Correlation Coefficient 0.9989 (Range 105.2-195.9 mmol/L)
K+: Slope 0.966, Intercept -0.13, Correlation Coefficient 0.9930 (Range 1.45-7.87 mmol/L)
Cl-: Slope 0.996, Intercept 0.62, Correlation Coefficient 0.9997 (Range 54.2-148.1 mmol/L)
The study proved that plasma can also apply to ISE test.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 862.1665 Sodium test system.
(a)
Identification. A sodium test system is a device intended to measure sodium in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of aldosteronism (excessive secretion of the hormone aldosterone), diabetes insipidus (chronic excretion of large amounts of dilute urine, accompanied by extreme thirst), adrenal hypertension, Addison's disease (caused by destruction of the adrenal glands), dehydration, inappropriate antidiuretic hormone secretion, or other diseases involving electrolyte imbalance.(b)
Classification. Class II.
0
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. ZHENG ZHE ENGINEER OF TECHNICAL REGULATION DEPARTMENT MINDRAY BUILDING, KEJI 12TH RD SOUTH, HI-TECH INDUSTRIAL PARK, NANSHAN, SHENZHEN, 518057 P.R. CHINA
June 9, 2016
Re: K160370
Trade/Device Name: BS-800M/ ABS800/BA-800M ISE KIT BS-800M Chemistry Analyzer BA-800M Chemistry Analyzer ABS-800 Chemistry Analyzer
Regulation Number: 21 CFR 862.1665 Regulation Name: Sodium Test System Regulatory Class: II Product Code: JGS, CGZ, CGZ, CEM, CDQ, JJE Dated: April 15, 2016 Received: May 2, 2016
Dear Zeng Zhe:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
1
medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulations (21 CFR Parts 801 and 809). please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Katherine Serrano -S
For:
Courtney H. Lias, Ph.D. Director Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K160370
Device Name
BS-800M Chemistry Analyzer, BA-800M Chemistry Analyzer, ABS800 Chemistry Analyzer, BS-800M/ABS800/BA-800M ISE Kit
Indications for Use (Describe)
The BS-800M/ABS800/BA-800M Chemistry Analyzer is designed for clinical chemistry laboratory use, making direct quantitative measurements of Na+(sodium), K+(potassium), Cl- (chloride) in serum, plasma and urine samples, and Urea Nitrogen in serum samples. Additionally, other various chemistry tests may be adaptable to the analyzer depending on the reagent used to induce a photometric reaction.
The BS-800M/ABS800/BA-800M ISE Kit is for the in vitro quantitative determination of Sodium (Na+), Potassium (K+), and Chloride (Cl-) concentrations in serum, plasma and urine samples on the The BS-800M/ABS800/BA-800M Chemistry Analyzer.
Sodium measurements monitor electrolyte balance and in the diagnosis and treatment of diseases involving electrolyte imbalance.
Potassium measurements monitor electrolyte balance and in the diagnosis and treatment of disease conditions characterized by, low or high blood potassium levels.
Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders.
Urea Nitrogen (BUN) measurements are used to aid in the determination of liver and kidney function and other diseases associated with protein catabolism.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D) | |
---|---|
Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR § 807.92.
The assigned 510(k) number is: K160370
Submitter:
Shenzhen Mindray Bio-medical Electronics Co., LTD Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057, P. R. China
Tel: +86 755 2658 2888 Fax: +86 755 2658 2680
● Contact Person:
Zeng Zhe
Shenzhen Mindray Bio-medical Electronics Co., LTD Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057, P. R. China
● Date Prepared:
June 2, 2016
Name of the device:
- Trade/Proprietary Name:
BS-800M Chemistry Analyzer, BA-800M Chemistry Analyzer, ABS800 Chemistry Analyzer, BS-800M/ABS800/BA-800M ISE Kit (BS-800M, BA-800M and ABS800 are the same analyzers except the appearance, logo and name of the models. For convenience of explanation, the BS-800M Chemistry Analyzer is
represented of the three in this summary.)
- Common Name: Clinical Chemistry Analyzer (with optional ISE Module)
- Classification Number/Class: ●
75JJE, Class I 75CDQ, Class II
4
75CEM, Class II 75CGZ, Class II 75JGS, Class II
Legally Marketed Predicate Device:
BS-200 Chemistry Analyzer, SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
K972671 BUN (LIQUID) REAGENT SET, POINTE SCIENTIFIC, INC.
Description:
The BS-800M/BA-800M/ABS800 Chemistry Analyzer is an automated clinical chemistry analyzer capable of performing various in vitro photometric assays. The BUN (LIQUID) REAGENT SET was cleared under K972671 and is the chosen assay to demonstrate performance for the photometric unit. The BS-800M Chemistry Analyzer has an optional Ion-Selective Electrode (ISE) module which measures the concentration of the electrolytes, sodium, potassium, and chloride, in samples using ion selective electrode technology.
Intended Use/ Indication for Use:
The BS-800M/ABS800/BA-800M Chemistry Analyzer is designed for clinical chemistry laboratory use, making direct quantitative measurements of Na+(sodium), K+ (potassium), Cl- (chloride) in serum, plasma and urine samples, and Urea Nitrogen in serum samples. Additionally, other various chemistry tests may be adaptable to the analyzer depending on the reagent used to induce a photometric reaction.
The BS-800M/ABS800/BA-800M ISE Kit is for the in vitro quantitative determination of Sodium (Na+), Potassium (K+), and Chloride (Cl-) concentrations in serum, plasma and urine samples on the The BS-800M/ABS800/BA-800M Chemistry Analyzer.
Sodium measurements monitor electrolyte balance and in the diagnosis and treatment of diseases involving electrolyte imbalance.
Potassium measurements monitor electrolyte balance and in the diagnosis and treatment of disease conditions characterized by, low or high blood potassium levels.
Chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders.
Urea Nitrogen (BUN) measurements are used to aid in the determination of liver and kidney function and other diseases associated with protein catabolism.
5
Comparison of Technological Characteristics:
Substantial equivalence has been demonstrated between the BS-800M Chemistry Analyzer and BS-200 Chemistry Analyzer. Both of them utilize absorbance photometry to perform and output quantitative results for kinetic and endpoint clinical chemistries. For analytes, BS-800M Chemistry Analyzer and BS-200 Chemistry Analyzer determine the concentration of unknown samples from a standard curve generated with known analyte concentrations. The BS-800M Chemistry Analyzer and BS-200 Chemistry Analyzer both utilize Ion-Selective Electrodes technology to measures the concentration of the electrolytes, sodium, potassium, and chloride in samples.
| Comparison
Section | BS-800M | BS-200
(Predicate Device) | |
|----------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------|
| 510(K) Number | K160370 | K072018 | |
| Intended use | The BS-800M/ABS800/BA-800M
Chemistry Analyzer is designed for
clinical chemistry laboratory use,
making direct quantitative
measurements of Na+(sodium), K+
(potassium), Cl- (chloride) in serum,
plasma and urine samples, and Urea
Nitrogen in serum samples.
Additionally, other various
chemistry tests may be adaptable to
the analyzer depending on the
reagent used to induce a photometric
reaction. | The BS-200 Chemistry Analyzer is
designed for clinical laboratory use,
making direct quantitative
measurements of Na+ (sodium), K+
(potassium), Cl-(chloride) in serum,
plasma and urine samples and
Glucose in serum samples.
Additionally, other various
chemistry assays may be adaptable
to the analyzer depending on the
reagent used to induce a photometric
reaction. | |
| Parameter(photometric) | BUN | BUN | |
| Parameter(ion selective
electrode) | Na+, K+, Cl⁻ | Na+, K+, Cl⁻ | |
| Comparison on photometric assay Chart 1: BS-800M and BS-200 analyzer | | | |
| Feature | BS-800M | BS-200
(Predicate Device) | Same
(S)/Different
(D) |
| 510(K) | K160370 | K072018 | / |
Comparison Table of BS-800M and Predicate Device:
6
1 | System Function | ||||
---|---|---|---|---|---|
System Control | Automatic, computer controlled | Automatic, microprocessor controlled | S | ||
LIS external connectivity capability | Yes | Yes | S | ||
Calibration/QC | Automatic and Manual calibration/QC | Automatic and Manual calibration/QC | S | ||
Barcode | Yes | Yes | S | ||
2 | Throughput (Max) | ||||
800 photometric tests per hour | |||||
1200 tests per hour with ISE | 200 photometric tests per hour | ||||
330 tests per hour with ISE | D | ||||
3 | Configuration | ||||
Analyzing unit, the Rack Feeder System, Operation unit, Output unit | Analytical unit, Operation unit, Output unit | D | |||
4 | Principle of Analysis | ||||
Mode of detection | Photometric | Photometric | S | ||
Analytical methods | Endpoint | ||||
Fixed-time | |||||
Kinetic | Endpoint | ||||
Fixed-time | |||||
Kinetic | S | ||||
Calibration methods | Linear calibration and nonlinear calibration | Linear calibration and nonlinear calibration | S | ||
5 | Optical Measurement Unit | ||||
Measurement Modes | Absorbance | Absorbance | S | ||
Optical Modes | Monochromatic, Bichromatic | Monochromatic, Bichromatic | S | ||
Photometer | Multi-wavelength, diffraction grating spectrophotometer | Multi-wavelength, Light transmission mode of the filter | D | ||
Wavelength | 340nm, 380nm, 412nm, 450nm, 505nm, 546nm, 570nm, 605nm, 660nm, 700nm, 740nm and 800nm | 340nm, 405nm, 450nm, 510nm, 546nm, 578nm, 630nm, 670nm | D | ||
Linear absorbance range | 0-3.4 absorbance | 0-4.0 absorbance | D | ||
Light Source | Tungsten halogen lamp | Tungsten halogen lamp | S | ||
Detector | Photodiode | Photodiode | S | ||
6 | Reaction Unit | ||||
Reaction cuvettes | Glass, 165 non-disposable | Plastic, 80 disposable | D | ||
Reaction volume | $100{\text{\textasciitilde}}360\mu L$ | $180{\text{\textasciitilde}}500\mu L$ | D | ||
Optical path | 5mm | 5mm | S | ||
Reaction temperature | 37°C | 37°C | S | ||
7 | Sample and Reagent System | ||||
Sample disk | 140 positions. 45 positions | ||||
respectively for outer two | |||||
circles of outer rings and 25 | |||||
positions respectively for | |||||
inter two circles of inter | |||||
rings | 40 sample tube positions on | ||||
the outer circle | D | ||||
Reagent disk | 120 positions. 50 positions | ||||
for inner circle and 70 | |||||
positions for outer circle. | 40 reagent bottle positions | ||||
on the inner circle | D | ||||
Pipttor System | Positive displacement | ||||
stepper motordrive | Positive displacement | ||||
stepper motor drive | S | ||||
Refrigerator temperature | 2-8°C | 4-15°C | D | ||
Sample Dispense | $1.5\mu L -50\mu L$ | $3\mu L -45\mu L$ | D | ||
Reagent Dispense | $15\mu L-300\mu L$ | $30\mu L-450\mu L$ | D | ||
8 | POWER | ||||
Input | $110/115V{\text{\textasciitilde}}\pm 10%, 60Hz\pm 1$ | ||||
Hz | $100-130V{\text{\textasciitilde}},50/60\pm 1 Hz$ | D | |||
Consumption | 3800VA | 1000 VA | D | ||
9 | Operating environmental conditions | ||||
Temperature | 15°C to 30°C | 15°C to 30°C | S | ||
Humidity | 35% to 85%, | ||||
non-condensing | 35% to 80%, | ||||
non-condensing | S | ||||
Comparison on Electrolytes assay Chart 2: BS-800M ISE module and BS-200 ISE module | |||||
Feature | BS-800M ISE Kit | BS-200 ISE Kit (Predicate | |||
Device) | Same | ||||
(S)/Different | |||||
(D) | |||||
510(K) | K160370 | K072018 | / | ||
1 | Indication for use/Intended Use | ||||
ISE Kit | The BS-800M/ ABS800/ | ||||
BA-800M ISE Module is | |||||
for the in vitro quantitative | |||||
determination of Sodium | The BS-200 ISE Module is | ||||
for the in vitro quantitative | |||||
determination of Sodium | |||||
(Na⁺), Potassium (K⁺), and | S | ||||
(Na+), Potassium (K+), and | |||||
Chloride (Cl-) | |||||
concentrations in serum, | |||||
plasma and urine samples | |||||
on the the BS-800M/ | |||||
ABS800/ | |||||
BA-800M | |||||
Chemistry Analyzer. | Chloride (Cl-) | ||||
concentrations in serum, | |||||
plasma and urine samples | |||||
on the the BS-200 | |||||
Chemistry Analyzer. | |||||
Sodium | Sodium measurements | ||||
monitor electrolyte balance | |||||
and in the diagnosis and | |||||
treatment of diseases | |||||
involving electrolyte | |||||
imbalance. | Sodium measurements | ||||
monitor electrolyte balance | |||||
and in the diagnosis and | |||||
treatment of diseases | |||||
involving electrolyte | |||||
imbalance. | S | ||||
Potassium | Potassium measurements | ||||
monitor electrolyte balance | |||||
and in the diagnosis and | |||||
treatment of disease | |||||
conditions characterized by, | |||||
low or high blood potassium | |||||
levels. | Potassium measurements | ||||
monitor electrolyte balance | |||||
and in the diagnosis and | |||||
treatment of disease | |||||
conditions characterized by, | |||||
low or high blood potassium | |||||
levels. | S | ||||
Chloride | Chloride measurements are | ||||
used in the diagnosis and | |||||
treatment of electrolyte and | |||||
metabolic disorders. | Chloride measurements are | ||||
used in the diagnosis and | |||||
treatment of electrolyte and | |||||
metabolic disorders. | S | ||||
2 | System Function | ||||
Method Principle | Ion Selective Electrode | Ion Selective Electrode | S | ||
Electrode | Na+ electrode, K+ | ||||
electrode, Cl- electrode, | |||||
reference electrode | Na+ electrode, K+ | ||||
electrode, Cl- electrode, | |||||
reference electrode, Space | |||||
electrode | D | ||||
Reference reagent | MR Serum Standard, MR | ||||
Urine Standard, MR Buffer | |||||
Solution, MR Detergent | |||||
Solution, MR Na/K Check | |||||
Solution | Reagent Pack, Urine | ||||
Diluent, Cleaning Solution, | D | ||||
ISE Internal | |||||
Standard | None | None | S | ||
Sample Volume | 22 µL total for all three tests | 70 µL Serum, plasma mode; | |||
140 µL Urine mode | D | ||||
ISE Throughput | |||||
Rate | 600 tests/hour | 300 tests/hour Serum, | |||
plasma mode; | D | ||||
Test Environment | 198 tests/hour Urine mode | ||||
Clinical Lab | S | ||||
3 | Calibration | ||||
Calibrator | MR Serum Standard for | ||||
Serum, Plasma mode; | |||||
MR Urine standard for | |||||
Urine mode; | ISE reagent pack for all | ||||
three sample types | D | ||||
Standardization | Na: NIST standard material | ||||
SRM919 | |||||
K: NIST standard material | |||||
SRM 918 | |||||
Cl: NIST standard material | |||||
SRM 919 | Na: NIST standard material | ||||
SRM956 | |||||
K: NIST standard material | |||||
SRM 956 | |||||
Cl: NIST standard material | |||||
SRM 956 | D | ||||
Calibrator Stability | 5°C~35°C, 12 months of | ||||
shelf-life, 8 weeks of in-use | |||||
stability | 4°C~25°C, 24 months of | ||||
shelf-life | D | ||||
Calibrator Matrix | Buffered Aqueous matrix | Buffered Aqueous matrix | S | ||
Calibrator Form | liquid | liquid | S | ||
Number of | |||||
Calibrator levels | Two for serum/Plasma and | ||||
Two for Urine | Two for serum/plasma/urine | S | |||
Calibration | |||||
Frequency | Daily | 8 hours | D | ||
4 | Performance Characters | ||||
Analytical | |||||
Measuring | |||||
(mmol/L) | Serum/Plasma | ||||
Na: 100-200 | |||||
K: 1-8 | |||||
Cl: 50-150 |
Urine
Na: 10-400
K: 5-200
Cl: 15-400 | Serum/Plasma
Na: 113-194
K: 1.1-8.6
Cl: 53-154
Urine
Na: 27-372
K: 13-184
Cl: 42-422 | D | |
| | Reference Interval | Serum(Adults):
Sodium: 136-145 mmol/L
Potassium: 3.5-5.1 mmol/L
Chloride: 98-107 mmol/L
Plasma(Adults):
Sodium: 136-145 mmol/L
Potassium: 3.4-4.5 mmol/L
Chloride: 98-107 mmol/L
Urine. 24 hour (Adults): | Serum(Adults):
Sodium: 136-145 mmol/L
Potassium: 3.5-5.1 mmol/L
Chloride: 98-107 mmol/L
Plasma(Adults):
Sodium: 136-145 mmol/L
Potassium: 3.4-4.5 mmol/L
Chloride: 98-107 mmol/L
Urine. 24 hour (Adults): | S | |
7
8
9
10
Sodium: 40-220 mmol/24h | Sodium: 40-220 mmol/24h | ||
---|---|---|---|
Potassium:25-125 mol/24h | Potassium:25-125 mol/24h | ||
Chloride:110-250 mol/24h | Chloride:110-250 mol/24h | ||
NSI Interferences | |||
concentration | Bilirubin | Bilirubin | D |
Na/K/Cl for three sample | Na/K/Cl for three sample | ||
types: 40 mg/dL | types: 20 mg/dL | ||
Hemoglobin | Hemoglobin | ||
Na/Cl for three sample | Na/K/Cl for three sample | ||
types: 500 mg/dL | types: 500 mg/dL | ||
Urine K: 500 mg/dL | |||
Lipemia | |||
Lipemia | Na/K/Cl for three sample | ||
Na/K/Cl for three sample | types: 1000 mg/dL | ||
types: 1000 mg/dL | |||
Ascorbic acid | |||
Na/K/Cl for three sample | |||
types: 30 mg/dL |
Performance Characteristics:
Performance testing of the BS-800M Chemistry Analyzer consisted of running the FDA previously cleared assay and the ISE module on the BS-800M to evaluate precision, linearity, and method comparison, Limits of Detection and Limits of Quantitation, interference, ISE plasma sample type studies.
A correlation analysis between the BS-800M Chemistry Analyzer and BS-200 Chemistry Analyzer yielded the following results:
| Analyte | Unit | Sample
Range | N | Slope | Intercept | Correlation
Coefficient |
|-----------|--------|-----------------|-----|-------|-----------|----------------------------|
| BUN | mg/dL | 5.4-149.5 | 122 | 0.98 | 0.81 | 0.9997 |
| Serum Na+ | mmol/L | 100.2-196.4 | 124 | 1.03 | -5.95 | 0.9966 |
| Serum K+ | mmol/L | 1.40-7.70 | 121 | 1.04 | -0.09 | 0.9994 |
| Serum Cl- | mmol/L | 50.4-149.4 | 124 | 1.00 | 0.15 | 0.9993 |
| Urine Na+ | mmol/L | 12.1-395.4 | 120 | 0.99 | -2.52 | 0.9997 |
| Urine K+ | mmol/L | 5.1-194.7 | 120 | 0.98 | -1.00 | 0.9997 |
| Urine Cl- | mmol/L | 15.2-381.3 | 120 | 0.97 | 2.06 | 0.9988 |
And the bias at the medical decision points of method comparison yielded the following
11
| Analyte | Unit | Medical decision points | Bias at the medical decision points
(Difference/Difference%) | | |
|-----------|--------|-------------------------|-----------------------------------------------------------------|--------------|--------------|
| | | | Point 1 | Point 2 | Point 3 |
| BUN | mg/dL | 6,26,50 | 0.696/11.6% | 0.317/1.2% | -0.138/-0.3% |
| Serum Na+ | mmol/L | 115,135,150 | -2.713/-2.4% | -2.149/-1.6% | -1.727/-1.2% |
| Serum K+ | mmol/L | 3.0,5.8,7.5 | 0.032/1.1% | 0.144/2.5% | 0.212/2.8% |
| Serum Cl- | mmol/L | 90,112 | 0.245/0.3% | 0.267/0.2% | / |
| Urine Na+ | mmol/L | 40,112 | -2.759/-6.9% | -3.837/-1.7% | / |
| Urine K+ | mmol/L | 25,125 | -1.418/-5.7% | -3.085/-2.5% | / |
| Urine Cl- | mmol/L | 110,250 | -1.112/-1.0% | -5.147/-2.1% | / |
results:
The total precision test of BS-800M yielded the following results:
| Analyte | Unit | Sample | n | Mean | Repeatability | | Within-Device
Precision | |
|-----------|--------|-------------------|----|-------|---------------|------|----------------------------|------|
| | | | | | SD | CV% | SD | CV% |
| BUN | mg/dL | Control
pool 1 | 80 | 11.0 | 0.28 | 2.5% | 0.33 | 3.0% |
| | mg/dL | Control
pool 2 | 80 | 46.4 | 0.57 | 1.2% | 0.94 | 2.0% |
| Serum Na+ | mmol/L | Control
pool 1 | 80 | 136.1 | 0.35 | 0.3% | 0.83 | 0.6% |
| | mmol/L | Control
pool 2 | 80 | 166.1 | 0.46 | 0.3% | 1.12 | 0.7% |
| Serum K+ | mmol/L | Control
pool 1 | 80 | 3.72 | 0.006 | 0.2% | 0.021 | 0.6% |
| | mmol/L | Control
pool 2 | 80 | 6.10 | 0.013 | 0.2% | 0.033 | 0.5% |
| Serum CL- | mmol/L | Control
pool 1 | 80 | 89.4 | 0.21 | 0.2% | 0.38 | 0.4% |
| | mmol/L | Control
pool 2 | 80 | 107.5 | 0.23 | 0.2% | 0.44 | 0.4% |
Page 9 of 14
12
pool 2 | ||||||||
---|---|---|---|---|---|---|---|---|
Urine Na+ | mmol/L | Control | ||||||
pool 1 | 80 | 87.1 | 0.22 | 0.3% | 0.44 | 0.5% | ||
Urine Na+ | mmol/L | Control | ||||||
pool 2 | 80 | 148.6 | 0.36 | 0.2% | 0.74 | 0.5% | ||
Urine K+ | mmol/L | Control | ||||||
pool 1 | 80 | 35.1 | 0.08 | 0.2% | 0.21 | 0.6% | ||
Urine K+ | mmol/L | Control | ||||||
pool 2 | 80 | 68.8 | 0.16 | 0.2% | 0.41 | 0.6% | ||
Urine Cl- | mmol/L | Control | ||||||
pool 1 | 80 | 90.4 | 0.20 | 0.2% | 0.40 | 0.4% | ||
Urine Cl- | mmol/L | Control | ||||||
pool 2 | 80 | 133.9 | 0.17 | 0.1% | 0.48 | 0.4% |
The linearity test of BS-800M yielded the following results:
| Analyte | Unit | Slope | Intercept | Correlation
Coefficient | Linear Range
Tested | Claimed
Linear
Range |
|--------------|--------|--------|-----------|----------------------------|------------------------|----------------------------|
| BUN | mg/dL | 0.9999 | 0.0053 | 0.9996 | 4.5-162.6 | 5-150 |
| Serum
Na+ | mmol/L | 0.9996 | 0.0783 | 1.0000 | 41.9-224.4 | 100-200 |
| Serum
K+ | mmol/L | 0.9997 | -0.0003 | 0.9999 | 0.61-9.34 | 1-8 |
| Serum
Cl- | mmol/L | 0.9998 | 0.0389 | 0.9999 | 11.0-162.4 | 50-150 |
| Urine
Na+ | mmol/L | 1.0000 | 0.0139 | 0.9999 | 7.5-469.5 | 10-400 |
| Urine K+ | mmol/L | 1.0001 | 0.0175 | 0.9999 | 3.1-254.4 | 5-200 |
| Urine
Cl- | mmol/L | 1.0000 | 0.0370 | 0.9999 | 10.9-439.4 | 15-400 |
The detection limit studies test of BS-800M yielded the following results:
Analyte | Unit | LoB | LoD | LoQ |
---|---|---|---|---|
BUN | mg/dL | 0.4 | 0.9 | 4.2 |
Serum Na+ | mmol/L | 1.9 | 3.5 | 39.5 |
Serum K+ | mmol/L | 0.04 | 0.05 | 0.54 |
Page 10 of 14
13
Serum Cl- | mmol/L | 0.5 | 0.6 | 9.5 |
---|---|---|---|---|
Urine Na+ | mmol/L | 0.9 | 1.4 | 6.9 |
Urine K+ | mmol/L | 0.1 | 0.2 | 2.4 |
Urine Cl- | mmol/L | 0.2 | 0.3 | 9.8 |
The Interference test of BS-800M yielded the following results:
Effects of bilirubin, hemoglobin, lipemia, ascorbic acid are tested, yielded the following results:
| Analyte | Analyte
concentration
(mmol/L) | Bilirubin
level(mg/dL) | Bias(mmol/L) | Comments |
|-----------|--------------------------------------|---------------------------|----------------|----------|
| BUN | 8.5
39.5 | 40 | +0.0
-0.1 | NSI |
| Serum Na+ | 134.0
154.8 | 40 | -0.4
+0.4 | NSI |
| Serum K+ | 3.23
5.94 | 40 | -0.01
+0.00 | NSI |
| Serum Cl- | 89.7
114.7 | 40 | -0.1
-0.2 | NSI |
| Urine Na+ | 45.9
224.1 | 40 | +0.6
-1.3 | NSI |
| Urine K+ | 26.9
127.3 | 40 | +0.0
-0.4 | NSI |
| Urine Cl- | 113.9
253.5 | 40 | +0.1
-1.5 | NSI |
Results of the bilirubin interference testing | ||
---|---|---|
Results of the hemoglobin interference testing
Analyte | Analyte concentration (mmol/L) | Hemoglobin level(mg/dL) | Bias(mmol/L) | Comments |
---|---|---|---|---|
BUN | 8.6 | |||
40.0 | 500 | +0.4 | ||
-0.1 | NSI | |||
Serum Na+ | 129.4 | |||
153.1 | 500 | +0.9 | ||
+0.9 | NSI | |||
Serum K+ | 3.15 | 125 | +0.30 | NSI |
≥250 | +0.61 | SI | ||
Serum K+ | 5.81 | 125 | +0.33 | NSI |
≥250 | +0.68 | SI |
Page 11 of 14
14
| Serum Cl- | 88.8
113.5 | 500 | +2.0
+2.6 | NSI |
|-----------|----------------|-----|--------------|-----|
| Urine Na+ | 45.1
223.4 | 500 | +1.5
+2.2 | NSI |
| Urine K+ | 29.3
135.0 | 500 | +1.5
+0.1 | NSI |
| Urine Cl- | 113.1
261.3 | 500 | +2.5
+1.8 | NSI |
Results of the lipemia interference testing
| Analyte | Analyte
concentration
(mmol/L) | Lipemia
level(mg/dL) | Bias(mmol/L) | Comments |
|-----------|--------------------------------------|-------------------------|----------------|----------|
| BUN | 8.3
38.2 | 1000 | -1.2
-1.1 | NSI |
| Serum Na+ | 125.3
147.6 | 1000 | -0.5
+0.4 | NSI |
| Serum K+ | 3.08
5.64 | 1000 | +0.05
+0.07 | NSI |
| Serum Cl- | 85.5
111.5 | 1000 | +0.0
-0.1 | NSI |
| UrineNa+ | 40.9
215.8 | 1000 | -0.1
-0.8 | NSI |
| Urine K+ | 28.1
127.8 | 1000 | +0.1
-0.6 | NSI |
| UrineCl- | 110.8
232.9 | 1000 | -0.2
-0.8 | NSI |
Results of the ascorbic acid interference testing
| Analyte | Analyte
concentration
(mmol/L) | Ascorbic Acid
level(mg/dL) | Bias(mmol/L) | Comments |
|-----------|--------------------------------------|-------------------------------|----------------|----------|
| BUN | 9.0
41.1 | 30 | -0.3
-0.4 | NSI |
| Serum Na+ | 132.9
153.4 | 30 | -0.3
+1.0 | NSI |
| Serum K+ | 3.19
5.89 | 30 | +0.00
+0.01 | NSI |
| Serum Cl- | 89.1
114.0 | 30 | -0.2
-0.4 | NSI |
Page 12 of 14
15
| Urine Na+ | 43.3
223.3 | 30 | +0.4
+0.8 | NSI |
|-----------|----------------|----|--------------|-----|
| Urine K+ | 29.7
125.0 | 30 | +0.1
-0.1 | NSI |
| Urine Cl- | 116.2
251.4 | 30 | +0.0
+0.3 | NSI |
There is no significant interference (NSI) observed when the concentrations of interference materials (including drugs) is below the ones in the following table
Interferents | Level tested(mg/dL) |
---|---|
Lipemia | 1000 |
Bilirubin | 40 |
Ascorbic Acid | 30 |
Imipramine | 0.15 |
Procainamide | 15 |
Nortriptyline | 0.26 |
Hydroxytyramine | 50.7 |
Ibuprofen | 512 |
Valproic acid | 75 |
Chlorpromazine | 6 |
Salicylic acid | 72 |
Acetylsalicylic acid | 1205 |
Erythromycin | 7.6 |
Ethosuximide | 30.6 |
Acetaminophen | 242 |
Benzalkonium Chloride | 10.4 |
Ampicillin | 6 |
There was significant interference for hemoglobin and Potassium Thiocynate.
- · Avoid Hemolyzed samples for potassium. Hemolyzed samples may give incorrect elevated potassium. Intracellular potassium concentration is 30-50 fold greater than that of extracellular serum or plasma.
- · Potassium thiocynate increases potassium by 0.55 mmol/L at the concentration of 3.30 mmol/L and by 0.58 mmol/L at the concentration of 5.39 mmol/L.
- Potassium thiocynate increases chloride by12.3 mmol/L at the concentration of 90.9 mmol/L and by12.6 mmol/L at the concentration of 114.6 mmol/L.
The BS-800M's sample type studies between serum and plasma of Na , K , Cl test yielded the following results, which proved the sample type plasma can also apply to ISE test:
16
| Analyte | Unit | N | Sample
Range | Slope | Intercept | Correlation
Coefficient |
|---------|--------|----|-----------------|-------|-----------|----------------------------|
| Na+ | mmol/L | 51 | 105.2-195.9 | 1.000 | -0.33 | 0.9989 |
| K+ | mmol/L | 51 | 1.45-7.87 | 0.966 | -0.13 | 0.9930 |
| Cl- | mmol/L | 51 | 54.2-148.1 | 0.996 | 0.62 | 0.9997 |
Conclusion:
The data demonstrates that the BS-800M Chemistry Analyzer is substantially equivalent to BS-200 Chemistry Analyzer.